Kinase Inhibitors

LY3143921 hydrate View larger

LY3143921 hydrate

AT9064

CAS 1627696-53-0

More details

Molarity Calculation Cart®

HOW TO ORDER

$38.00

$38.00 per mg

Quantity Discount Table - Order More To Get More Price Discount

QuantitymgUnit Price ($/mg or $/Unit)Final Price
1100 $17.10 Total: $1,710.00
150 $19.76 Total: $988.00
125 $23.18 Total: $579.50
110 $27.36 Total: $273.60
15 $32.30 Total: $161.50

Data sheet

Molecular FormulaC16H14FN5O2
Molecular Weight327.31
CAS Numbers1627696-53-0
Storage Condition0C Short Term, -20C Long Term
SolubilityDMSO
Purity98% by HPLC
SMILES CodeC[C@]1(C2=C(C=C(C=C2)C3=CNN=C3)C(=O)N1)C4=NC=NC=C4F.O
ReferencesGallagher P F , Coyle V , Evans T , et al. A CRUK first-in-human phase I trial of a CDC7 Inhibitor, LY3143921 hydrate, in patients with advanced solid tumors.[J]. Journal of Clinical Oncology, 2019, 37[15_suppl] TPS3167-TPS3167.

More info

LY3143921 ((S)-Example 2) hydrate is an orally active CDC7 kinase inhibitor with broad in vitro anticancer activity [1].